Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China
· Delayed Price · Currency is CNY 48.13
+0.31 (0.65%)
At close: May 13, 2025, 2:57 PM CST
SHE:301617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 957.84 | 228.52 | 80 | 46.5 | 19.86 | Upgrade
|
| Trading Asset Securities | - | - | 69.15 | 23.52 | 5 | Upgrade
|
| Cash & Short-Term Investments | 957.84 | 228.52 | 149.15 | 70.02 | 24.86 | Upgrade
|
| Cash Growth | 319.15% | 53.22% | 112.99% | 181.71% | -37.52% | Upgrade
|
| Accounts Receivable | 182.43 | 169.27 | 121.25 | 105.25 | 111.3 | Upgrade
|
| Other Receivables | 1.63 | 4.7 | 0.74 | 2.43 | 8.73 | Upgrade
|
| Receivables | 184.06 | 173.97 | 121.99 | 107.67 | 120.03 | Upgrade
|
| Inventory | 210.39 | 171.37 | 137.1 | 104.03 | 76.53 | Upgrade
|
| Prepaid Expenses | - | - | 0.47 | - | - | Upgrade
|
| Other Current Assets | 25.62 | 21.02 | 11.72 | 28.17 | 10.73 | Upgrade
|
| Total Current Assets | 1,378 | 594.88 | 420.43 | 309.89 | 232.15 | Upgrade
|
| Property, Plant & Equipment | 436.96 | 369.2 | 331.44 | 187.82 | 159.2 | Upgrade
|
| Other Intangible Assets | 55.23 | 56.54 | 58.32 | 58.01 | 20.41 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.69 | 0.67 | 0.36 | 0.72 | 0.68 | Upgrade
|
| Other Long-Term Assets | 1.22 | 1.72 | 1.1 | 2.58 | 6.39 | Upgrade
|
| Total Assets | 1,872 | 1,023 | 811.65 | 559.02 | 418.84 | Upgrade
|
| Accounts Payable | 164.76 | 143.08 | 134.32 | 51.92 | 59.02 | Upgrade
|
| Accrued Expenses | 14.25 | 14.94 | 15.7 | 13.42 | 8.5 | Upgrade
|
| Short-Term Debt | - | - | 1 | 0.38 | 28.47 | Upgrade
|
| Current Portion of Long-Term Debt | 0.27 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.26 | 0.97 | 1.1 | - | Upgrade
|
| Current Income Taxes Payable | 10.95 | 4.71 | 2.33 | 4.39 | - | Upgrade
|
| Current Unearned Revenue | 4.01 | 4.39 | 2.86 | 4.4 | 2.35 | Upgrade
|
| Other Current Liabilities | 27.84 | 46.78 | 26.36 | 31.72 | 23.57 | Upgrade
|
| Total Current Liabilities | 222.08 | 214.16 | 183.56 | 107.33 | 121.91 | Upgrade
|
| Long-Term Leases | - | 0.27 | 0.6 | 1.43 | - | Upgrade
|
| Total Liabilities | 222.08 | 214.43 | 184.16 | 108.76 | 121.91 | Upgrade
|
| Common Stock | 102.8 | 77.1 | 77.1 | 77.1 | 73.4 | Upgrade
|
| Additional Paid-In Capital | 842.45 | 239.32 | 238.83 | 238.25 | 191.24 | Upgrade
|
| Retained Earnings | 704.25 | 491.13 | 309.02 | 132.7 | 29.41 | Upgrade
|
| Comprehensive Income & Other | 0.42 | 1.03 | 2.54 | 2.21 | 2.88 | Upgrade
|
| Shareholders' Equity | 1,650 | 808.58 | 627.49 | 450.26 | 296.92 | Upgrade
|
| Total Liabilities & Equity | 1,872 | 1,023 | 811.65 | 559.02 | 418.84 | Upgrade
|
| Total Debt | 0.27 | 0.53 | 2.58 | 2.9 | 28.47 | Upgrade
|
| Net Cash (Debt) | 957.57 | 227.99 | 146.57 | 67.12 | -3.61 | Upgrade
|
| Net Cash Growth | 320.00% | 55.55% | 118.37% | - | - | Upgrade
|
| Net Cash Per Share | 12.40 | 2.96 | 1.90 | 0.91 | -0.05 | Upgrade
|
| Filing Date Shares Outstanding | 77.58 | 77.1 | 77.1 | 77.1 | 73.4 | Upgrade
|
| Total Common Shares Outstanding | 77.58 | 77.1 | 77.1 | 77.1 | 73.4 | Upgrade
|
| Working Capital | 1,156 | 380.72 | 236.87 | 202.56 | 110.24 | Upgrade
|
| Book Value Per Share | 21.27 | 10.49 | 8.14 | 5.84 | 4.05 | Upgrade
|
| Tangible Book Value | 1,595 | 752.05 | 569.17 | 392.25 | 276.51 | Upgrade
|
| Tangible Book Value Per Share | 20.56 | 9.75 | 7.38 | 5.09 | 3.77 | Upgrade
|
| Buildings | - | 135.44 | 56.68 | 56.19 | 54.67 | Upgrade
|
| Machinery | - | 171.13 | 153.79 | 147.45 | 108.51 | Upgrade
|
| Construction In Progress | - | 149.81 | 187.42 | 35.07 | 34.78 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.